Lindhout et al., 1995 - Google Patents
Kinetics of the inhibition of tissue factor-factor Vila by tissue factor pathway inhibitorLindhout et al., 1995
- Document ID
- 10307863251537608396
- Author
- Lindhout T
- Franssen J
- Willems G
- Publication year
- Publication venue
- Thrombosis and haemostasis
External Links
Snippet
Tissue factor-factor VIIa catalysed activation of factor X and factor IX is inhibited by the complex of tissue factor pathway inhibitor (TFPI) and factor Xa. At present, no information is available as to what extent the kinetics of complex formation between TFPI and factor Xa …
- 101710034269 TFPI 0 title abstract description 141
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindhout et al. | Kinetics of the inhibition of tissue factor-factor Vila by tissue factor pathway inhibitor | |
| Repke et al. | Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. | |
| US6017882A (en) | Modified vitamin K-dependent polypeptides | |
| US9266931B2 (en) | Modified vitamin K-dependent polypeptides | |
| Oesterud et al. | Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX | |
| US7294699B2 (en) | Modified vitamin K-dependent polypeptides | |
| Hamamoto et al. | Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. | |
| Rezaie | Exosite-dependent regulation of the protein C anticoagulant pathway | |
| van Dieijen et al. | Assembly of the intrinsic factor X activating complex–interactions between factor IXa, factor VIIIa and phospholipid | |
| KR20140033010A (en) | Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor | |
| WIJNEN et al. | Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain | |
| Segers et al. | The role of thrombin exosites I and II in the activation of human coagulation factor V | |
| Long et al. | Human protein S cleavage and inactivation by coagulation factor Xa | |
| Bourin et al. | Functional role of the polysaccharide component of rabbit thrombomodulin proteoglycan. Effects on inactivation of thrombin by antithrombin, cleavage of fibrinogen by thrombin and thrombin-catalysed activation of factor V | |
| US7220837B1 (en) | Modified vitamin K-dependent polypeptides | |
| Rezaie et al. | Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin | |
| Yang et al. | Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa | |
| Franssen et al. | Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor | |
| Bertina et al. | Factor IXa protects activated factor VIII against inactivation by activated protein C | |
| De Cristofaro et al. | Effect of sodium on the energetics of thrombin–Thrombomodulin interaction and its relevance for protein C hydrolysis | |
| NEMERSON | Hemophilia as a defect of the tissue factor pathway of blood coagulation: Effect of factors VIII and IX on factor X activation ina continuous-flow reactor | |
| Chmielewska et al. | On the kinetics of the inhibition of plasminogen activators by the plasminogen activator inhibitor PAI-1 | |
| MXPA00003916A (en) | Modified vitamin k-dependent polypeptides |